Biomarker analysis
Biomarker development and validation for personalized medicine
For R&D in diagnostics and medical research institutions.
QuoData’s comprehensive biomarker development and validation services:
- powerful designs for biomarker validation studies and development of new mathematical methods for the simultaneous evaluation of biomarker panels
- detailed personalized analysis of the statistical behaviour of biomarker panels and their relevance for therapy monitoring and prediction
- sophisticated decision rules for therapy intervention
Given the potential of biomarkers for diagnostics, patient stratification and therapy monitoring in oncology, the identification and validation of new biomarkers is an important and promising task for contemporary clinical research.
Take advantage of our expertise in the development and validation of biomarkers!
QuoData publications with regard to biomarker development
Novel Serum Nucleosomics Biomarkers for the Detection of Colorectal Cancer
Holdenrieder, Stefan; Dharuman, Yoganiranjana; Standop, Jens; Trimpop, Nicolai; Herzog, Marielle; Hettwer, Karina et al. (2014)
Published in:
Anticancer Research (34), p. 2357–2362
Apoptosis-related biomarkers in patients with gynecological cancer
Hermann, Natalie; Dressen, Katja; Schroeder, Lars; Debald, Manuel; Keyver-Paik, Mignon; Abramian, Alina et al. (2015)
Published in:
CP 53 (12), p. 1059–1061
Apoptosis-related biomarkers in patients with gastrointestinal cancer.
Dressen, Katja; Hermann, Natalie; Manekeller, Steffen; Bruenagel, Gisela Walgenbach; Schildberg, Frank A.; Hettwer, Karina et al. (2015)
Published in:
CP 53 (12), p. 1062–1064.